Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma

Clinical Trial ID NCT00142428

PubWeight™ 4.32‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00142428

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2010 2.07
2 Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget 2012 1.55
3 Targeted therapies in the treatment of advanced hepatocellular carcinoma. Clin Med Insights Oncol 2013 0.83
Next 100